Home / Health / GLP-1 Drugs Linked to Unusual Menstrual Side Effects
GLP-1 Drugs Linked to Unusual Menstrual Side Effects
10 Aug
Summary
- GLP-1 medications may be linked to menstrual changes like heavy periods.
- FDA data shows higher rates of menstrual clots and bleeding with semaglutide.
- Weight loss alone may not explain these specific reported menstrual changes.
Millions globally are using GLP-1 medications, including Ozempic and Zepbound, for weight management. Beyond common gastrointestinal issues, a recent analysis indicates these drugs may be associated with significant menstrual changes. The study, published in Obstetrics & Gynecology in July, examined the FDA's Adverse Event Reporting System (FAERS).
Researchers found that semaglutide and tirzepatide users reported menstrual clots and heavy bleeding at rates significantly higher than expected. Semaglutide showed the most prominent signal, with reports of menstrual clots occurring over 30 times the expected rate. However, the study's reliance on voluntary reports means definitive causation cannot be established.
Experts caution that while these findings warrant awareness, they are not generalizable to all users. Some anecdotal evidence suggests GLP-1s might even improve menstrual regularity for certain conditions. Further real-time studies are recommended to better understand the potential connection between these popular medications and menstrual cycle alterations.
